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One of the challenges for the clinical translation of RNA interference (RNAi)-based therapies concerns the
deposition of therapeutically effective doses of the nucleic acids, like siRNA, at a local tissue level without
severe off-target effects. To address this issue, hydrogels can be used as matrices for the local and sus-
tained release of the siRNA cargo. In this study, the formation of polyplexes based on siRNA and poly(2-
dimethylaminoethyl methacrylate) (PDMAEMA)-based polymers was investigated, followed by their
loading in a thermosensitive hydrogel to promote local siRNA release. A multifunctional NPD triblock
copolymer consisting of a thermosensitive poly(N-isopropylacrylamide) (PNIPAM, N), a hydrophilic poly
(ethylene glycol) (PEG, P), and a cationic PDMAEMA (D) block was used to study the binding properties
with siRNA taking the non-thermosensitive PD polymer as control. For both polymers, small polyplexes
with sizes ranging from 10–20 nm were formed in aqueous solution (HBS buffer, 20 mM HEPES, 150 mM
NaCl, pH 7.4) when prepared at a N/P charge ratio of 5 or higher. Formulating the siRNA into NPD or PD
polyplexes before loading into the thermosensitive PNIPAM–PEG–PNIPAM hydrogel resulted in a more
controlled and sustained release compared to free siRNA release from the hydrogel. The polyplexes were
released for 128 hours in HBS, when changing the release medium twice a day, while free siRNA was
completely released within 50 hours with already 40% being released after changing the release medium
just once. The release of the polyplexes was dependent on the dissolution rate of the hydrogel matrix.
Moreover, intact polyplexes were released from the hydrogels with a similar size as before loading,
suggesting that the hydrogel material did not compromise the polyplex stability. Finally, it was shown that
the released polyplexes were still biologically active and transfected FaDu cells, which was observed by
siRNA-induced luciferase silencing in vitro. This study shows the development of an injectable thermo-
sensitive hydrogel to promote local and sustained release of siRNA, which can potentially be used to
deliver siRNA for various applications, such as the treatment of tumors.
1. Introduction
Since the discovery of RNA interference (RNAi) by Fire and
Mello in 1998,1 many researchers have focused on using this
for therapeutic purposes. RNAi is a biological process in which
RNA molecules, like microRNA (miRNA) and small interfering
RNA (siRNA), inhibit gene expression by binding to comp-
lementary messenger RNA (mRNA) resulting in silencing of
the protein expression. The process is exploited to knock down
specific genes creating many opportunities for treating dis-
eases. Despite the high potential of these nucleic acid thera-
peutics, translation has been limited and only recently the first
siRNA therapy was approved by the FDA.2,3 Efficient delivery of
siRNA molecules in the target cells remains the major chal-
lenge for clinical translation. Nucleic acids are highly nega-
tively charged and large hydrophilic molecules, making them
unable to pass cellular membranes by passive diffusion.
Moreover, siRNAs have a half-life of only a few minutes after
intravenous administration due to their susceptibility to degra-
dation by nucleases in the bloodstream and rapid renal clear-
ance.4 Other challenges include induction of immune
responses and off-target effects.5 To facilitate the intracellular
delivery of siRNA, non-viral polymer-based systems have been
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widely studied both in vitro and in vivo.6–8 Cationic polymers
form complexes (i.e. polyplexes) with the negatively charged
siRNA molecules exploiting electrostatic interactions, and
these polyplexes protect siRNA from degradation and promote
cellular uptake. A great variety of cationic polymers have been
developed as nucleic acid carriers, including polyethylenimine
(PEI), poly-L-lysine (PLL), polyamidoamine (PAMAM), and poly
(2-dimethylaminoethyl methacrylate) (PDMAEMA).9–11 The
advantages of these polymeric deliver systems are their tailor-
able design, the relatively ease to scale-up the production, and
they are safer as compared to viral vectors. However, one of the
challenges that remains is the accumulation of therapeutically
effective doses of siRNA at a local tissue level with acceptable
off-target effects.12,13 To address these limitations, hydrogels
can be used to facilitate local and sustained release of siRNA.
Hydrogels are water-swollen cross-linked networks of hydro-
philic polymers, which have been used for the delivery of
various biomolecules, including siRNA.14–17 The nucleic acids
are entrapped within the hydrogel either as siRNA conjugates
or loaded in nanoparticles, and the release kinetics can be
tuned by varying hydrogel properties such as polymer concen-
tration and cross-link density.17,18 In this way, hydrogels assist
in local retention and sustained release of siRNA to enhance
in vivo efficacy and at the same time limit off-target toxicity.18
While many hydrogels have been investigated for local
release of therapeutics, injectable formulations are preferred
over preformed hydrogels, since in situ gelation can take place
under physiological conditions upon injection without the
need of an invasive surgical intervention.19–21 Especially the
use of stimuli-responsive polymers gained a lot of interest, as
they can respond to external environmental triggers, like temp-
erature, pH or light exposure.17 Temperature-sensitive hydro-
gels are one of the most studied class of stimuli-responsive
polymer systems, and the self-assembly of these polymers
occurs at a critical temperature, the so-called cloud point (CP)
in aqueous solution. Because poly(N-isopropylacrylamide)
(PNIPAM)-based polymers have a CP around 32 °C, they are
very attractive materials for biomedical and pharmaceutical
applications.22,23
Previously, a multifunctional triblock copolymer consisting
of a thermosensitive PNIPAM, an hydrophilic poly(ethylene
glycol) (PEG) and a cationic PDMAEMA block was investigated
for the release of plasmid DNA (pDNA). The presented results
showed that multiple functionalities can be introduced in the
polymer design without compromising the interactions with
pDNA and hence the polyplex structure.24 The aim of the
present study is to investigate the applicability of the thermo-
sensitive polyplexes based on the NPD (N = PNIPAM, P = PEG,
D = PDMAEMA) triblock copolymer for siRNA delivery.
Furthermore, the loading of these polyplexes into a thermosen-
sitive PNIPAM–PEG–PNIPAM hydrogel was evaluated to facili-
tate local and sustained release of siRNA. First, the physical–
chemical properties of polyplexes formed between siRNA and
the multifunctional NPD polymer were evaluated taking a non-
thermosensitive polymer as control. Second, the release profile
of polyplexes from the thermosensitive PNIPAM–PEG–PNIPAM
hydrogel was evaluated as well as the ability of the released
polyplexes to deliver siRNA in vitro into cells.
2. Materials and methods
2.1. Materials
All materials were obtained from Sigma-Aldrich (Zwijndrecht,
the Netherlands) and used as received unless noted otherwise.
Acetonitrile (ACN) and N,N-dimethylformamide (DMF) were
purchased from Biosolve (Valkenswaard, the Netherlands) and
DMF was dried by molecular sieves for 24 hours before use. To
remove the inhibitor from 2-(dimethylamino)ethyl methacry-
late (DMAEMA), the monomer was passed over a column
of alumina prior to use. Slide-A-lyzer™ Dialysis cassettes
(Molecular weight cut-off, MWCO: 10 kDa) were obtained
from Thermo Fisher Scientific (Bleiswijk, the Netherlands).
Agarose multi-purpose was purchased from Roche Molecular
Biochemicals (Mannheim, Germany) and Midori Green DNA
gel stain was obtained from Nippon Genetics (Düren,
Germany). Human epithelial hypopharyngeal carcinoma cells
stably expressing luciferase (FaDu-luc) were obtained from
Erasmus Medical Center (Rotterdam, the Netherlands).25
Linear polyethylenimine (l-PEI, Mw 25 kDa) was obtained
from Polysciences (Hirschberg an der Bergstraße, Germany).
Lipofectamine 3000, alamarBlue™ Cell Viability Reagent and
Quant-iT™ RiboGreen™ RNA Assay Kit were purchased from
Thermo Fisher Scientific and Luciferase assay kit was obtained
from Promega (Leiden, the Netherlands).
The siRNA specifically targeting firefly luciferase and the
negative control siRNA were provided by GlaxoSmithKline
(Stevenage, UK) and their sequences are shown in Table 1.
siRNA labeled with Alexa 647 was used for fluorescence corre-
lation spectroscopy (FCS) experiments and this Alexa 647
labeled siRNA has the negative control sequence with the label
present at the 3′ end of the sense strand.
2.2. Synthesis and characterization of polymers
2.2.1. Synthesis of NPD triblock copolymers. The triblock
copolymer consisting of PNIPAM–PEG–PDMAEMA (NPD)
was synthesized following a two-step procedure using the
hetero-functional PEG macroinitiator ((Br–C(CH3)2–CO–NH–
PEG5000)2–ABCPA) as previously reported.
26 The first step
involved atom transfer radical polymerization of NIPAM. For
this, the PEG macroinitiator (1 equiv.), NIPAM (283 equiv.) and
Table 1 Overview of siRNA sequences used
siRNA Sequence
Luciferase siRNA
(siRNA-luc)
Sense 5′-C̲U̲U̲-AC ̲G-C̲U̲G-AGU̲-AC̲U̲-U̲C̲G-AdTdT-3′
Antisense 5′-
UCG-AAG-UAC-UCA-GCG-UAA-GdTdT-3′
Negative control
siRNA (siRNA-nc)
Sense 5′-AUC̲-GU̲A-C ̲GU̲-AC ̲C-GU̲C-GU̲A-U̲dTdT-3′
Antisense 5′-AU̲A-C̲GA-C̲GG-U̲AC̲-GU̲A-C̲GA-U̲dTdT-3′
Underlined bases indicate a 2′O-methyl modification. dT indicates a
deoxyribonucleic acid base having phosphorothioate (PS) bond.
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CuBr (8 equiv.) were dissolved in 3.5 mL water in an airtight
screw-cap glass vial with a final NIPAM concentration of 90 mg
mL−1. The reaction mixture was flushed with nitrogen for
15 min at room temperature (RT) and subsequently another
15 min on ice. Next, 18 equiv. of tris[2-(dimethylamino)ethyl]
amine (Me6TREN) as catalyst was added and the polymeriz-
ation reaction was carried out for three hours on ice.
Subsequently, the polymer solution was transferred into a
dialysis cassette (MWCO: 10 kDa) and dialyzed against water
for 48 hours at 4 °C, while changing the dialysate three times a
day. The resulting NPPN polymer was recovered by freeze
drying. The second step of the polymerization route involved
the synthesis of the PDMAEMA block by free radical polymeriz-
ation. The NPPN polymer (1 equiv.) and DMAEMA (790 equiv.)
were dissolved in dry DMF in an airtight Schlenk flask with a
final DMAEMA concentration of 300 mg mL−1. Freeze–pump–
thaw cycles were applied to degas the solution, and afterwards
vial with the reaction mixture was placed in an oil bath at
70 °C and stirred for 24 hours under N2 atmosphere. Next, the
polymer solution was dialyzed (MWCO: 10 kDa) against water
for 48 hours at 4 °C, while changing the dialysate three times a
day, and subsequently freeze dried to obtain the final NPD
polymer. As a control, a non-thermosensitive polymer lacking
the PNIPAM block was synthesized. For this, a PEG macroini-
tiator without ATRP initiator (Boc–NH–PEG5000)2–ABCPA
(1 equiv.) together with DMAEMA (800 equiv.) were dissolved
in dry DMF and the same procedure as described above was
applied resulting in the corresponding PD diblock polymer.
2.2.2. Synthesis of NPN triblock copolymers. The triblock
copolymer consisting of PNIPAM–PEG–PNIPAM (NPN) was syn-
thesized following a previously reported procedure using the
PEG macroinitiator ((Br–C(CH3)2–COO)2–PEG6000).
27 In brief,
the PEG macroinitiator (1 equiv.), NIPAM (302 equiv.), CuBr
(1 equiv.) and CuBr2 (1 equiv.) were placed in an airtight screw-
cap glass vial and 12 mL of H2O/ACN (4 : 1) mixture was added.
The reaction mixture was flushed with nitrogen and placed in
an ice bath while stirring until all compounds were completely
dissolved. Subsequently, 2 equiv. of Me6TREN was added and
the polymerization reaction was carried out for one hour on
ice. The polymer solution was dialyzed (MWCO: 10 kDa)
against water for 48 hours at 4 °C, while changing the dialysate
three times a day and subsequently lyophilized.
2.2.3. Characterization of polymers. The synthesized poly-
mers were characterized with 1H-NMR spectroscopy using an
Agilent 400 MR-NMR spectrometer (Agilent Technologies,
Santa Clara, CA, USA). Chemical shifts are referred to the
residual solvent peak (δ = 7.26 ppm for CDCl3 and δ =
4.80 ppm for D2O) and data analysis was performed using
MestReNova Software version 10.0.1-14719. The obtained poly-
mers were also characterized by GPC using a Waters Alliance
System (Waters Corporation, Milford, MA, USA) equipped with
a refractive index (RI) detector and a PLgel 5 µm MIXED-D
column (Polymer Laboratories) using DMF containing 10 mM
LiCl as eluent.28 The flow rate was 1.0 mL min−1 and 50 µL of
polymer solution (3 mg mL−1) was injected into the column.
The column temperature was 65 °C and calibration was per-
formed using PEG standards of narrow and defined molecular
weights (PSS GmbH, Mainz, Germany). Data analysis was per-
formed using Empower 3 Software 2010. The cloud point (CP)
of the synthesized thermosensitive polymers was determined
by light scattering using a Jasco FP-8300 spectrophotometer
(JASCO, Easton, MD). Samples of the polymers were prepared
at a concentration of 2 mg mL−1 in 20 mM N-(2-hydroxyethyl)
piperazine-N′-(2-ethanesulfonic acid) (HEPES) buffer, pH 7.4.
The scattering intensity of the polymer solution was measured
at 550 nm while increasing the temperature from 10 to 60 °C
with a heating rate of 1 °C min−1. The onset of increased scat-
tering intensity was taken as the cloud point.29
2.3. Polyplex preparation
Polymer stock solutions (ranging from 110–1370 µg mL−1,
depending on polymer type and intended N/P ratio), and
siRNA stock solution (30 µM) were prepared in HBS buffer
(20 mM HEPES, 150 mM NaCl, pH 7.4) and cooled at 0 °C.
Next, the polymer solution was added to the siRNA solution in
a 2 : 1 volume ratio (typically 400 : 200 µL), and the mixture was
vortexed for 10 seconds. The formed polyplexes were incubated
at 0 °C for 30 minutes before further use.
2.4. Polyplex characterization
2.4.1. Dynamic light scattering (DLS) and laser Doppler
electrophoresis (LDE) analysis of polyplexes. DLS was used to
determine the hydrodynamic size and polydispersity index
(PDI) of the formed polyplexes. Samples were prepared as
described in section 2.3 at a final siRNA concentration of
10 µM in HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4).
The measurements were performed on a Zetasizer Nano S
(Malvern Instruments, Malvern, UK) with an He–Ne laser oper-
ating at 633 nm, and temperature controller set at 10 and
37 °C. Data were corrected for viscosity using the Malvern
Zetasizer software (version 7.12). The ζ-potential of the poly-
plexes was measured using laser Doppler electrophoresis on a
Zetasizer Nano Z (Malvern Instruments). For this, samples
were prepared in HEPES buffer (20 mM HEPES, pH 7.4) with a
siRNA concentration of 10 µM.
2.4.2. Agarose gel retardation assay. Polyplex dispersions
were prepared as described in section 2.3 and diluted with
HBS to a final siRNA concentration of 1 µM. To assess the
stability in the presence of serum, the polyplexes dispersed in
10% fetal bovine serum (FBS) were incubated for 2, 4, and
6 hours at 37 °C. Next, 10 µL of the polyplex sample was mixed
with 2 µL heparin sodium salt solution (20 mg mL−1) or 2 µL
HBS buffer and incubated for 1 hour at room temperature.
Afterwards, 2 µL of 6× loading dye was added to the mixture
and loaded into a 1.5% agarose gel containing Midori Green
in a tris-acetate-EDTA (TAE) buffer. The gel was run at 35 V for
40 minutes and analyzed by a ChemiDoc™ Imager (Bio-Rad
Laboratories Inc., Hercules, CA) using Image Lab software
(version 6.0.1).
2.4.3. Fluorescence correlation spectroscopy (FCS). The
size of fluorescently labeled siRNA polyplexes was investigated
by FCS measurements as previously described.30 Fluorescently
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labeled particles continuously move in and out of the detec-
tion volume (i.e. confocal volume), causing fluctuations in the
fluorescence signal. From these fluctuations, an auto-corre-
lation curve can be derived that subsequently gives infor-
mation about the diffusion coefficient of the fluorescent par-
ticles present in the detection volume.31,32 Polyplexes contain-
ing Alexa 647 labeled siRNA were prepared as described in
section 2.3 and subsequently diluted with HBS buffer to a final
siRNA concentration of 150 nM. To assess the stability, the
polyplexes were incubated for 6 hours at 37 °C with or without
10% FBS. Afterwards, 40 µL of each sample was transferred
onto a coverslip (µ-slide Ibidi, Gräfelfing, Germany). The cover-
slip was placed in a temperature controlled plate to maintain
the temperature of the sample at 37 °C. FCS measurements
were performed using a confocal microscope (Nikon C1,
Japan) equipped with a 640 nm laser and a water immersion
objective lens (60× Plan Apo VC, N.A. 1.2, Nikon). For each
sample, the fluctuations of fluorescence intensity were
recorded by a photon counting instrument (PicoHarp 300,
PicoQuant, Berlin, Germany) for 60 seconds in triplicate. The
obtained time traces were analyzed using SymPhoTime
(PicoQuant) and data were fitted using the triple-state model
to obtain diffusion coefficients and concentration of fluo-
rescent particles or molecules. The size was determined using
the Stokes–Einstein equation.
D ¼ kBT
6πηRH
ð1Þ
In which D is the diffusion coefficient, kB the Boltzmann’s
constant, T the absolute temperature, η the viscosity, and RH
the hydrodynamic radius of the particle.
2.5. Hydrogel formation and polyplex/siRNA release
The NPN polymers (final concentration of 15% w/w) were dis-
solved in the NPD or PD polyplexes dispersions (N/P 5 mol/
mol, final siRNA concentration of 500 µM) overnight at 4 °C.
Free siRNA (thus not formulated as polyplexes; same final con-
centration) was included as a control. Next, the glass vials were
placed at 37 °C and gels (100 µL) were allowed to form. After
30 minutes, 500 µL of prewarmed release buffer (HBS, 20 mM
HEPES, 150 mM NaCl, pH 7.4) of 37 °C was added on top of
the hydrogels. Twice a day, 450 µL of the release medium was
replaced with fresh prewarmed release buffer and the concen-
tration of siRNA in the samples was determined using the
RiboGreen Assay (section 2.6).
2.6. Quantification of siRNAwith Quant-iT™ RiboGreen™ assay
The amount of siRNA released from the thermosensitive
hydrogel was quantified using an intercalating reagent that
produces a fluorescent signal. First, release samples were
diluted 100 times and 40 µL was transferred into a 96-well
plate. Next, 55 µL of heparin solution (4.5 mg mL−1) was
added to the release samples and incubated for 1 hour at RT
to destabilize the polyplexes. Next, the commercially available
Quant-iT™ RiboGreen® RNA Assay Kit was used according
to the manufacturer’s protocol and the ‘high range assay’
(20 ng mL−1 to 1 µg mL−1) was selected. The siRNA’s with the
same sequences were used for calibration and the fluorescence
signal was measured at 484/520 nm using a Jasco FP-8300
spectrophotometer (JASCO, Easton, MD).
2.7. Characterization of released polyplexes by fluorescence
correlation spectroscopy (FCS)
The size of the released polyplexes from the thermosensitive
hydrogel was determined by FCS measurements. Polyplexes
containing Alexa 647 labeled siRNA were prepared as described
in section 2.3 and subsequently loaded in thermosensitive
hydrogels as described in section 2.5. Release medium was
refreshed twice a day and at predetermined timepoints (8 and
72 hours) 40 µL of the release medium was transferred onto a
coverslip. In parallel, to destabilize the polyplexes, 90 µL of the
release medium was mixed with 10 µL heparin sodium
salt solution (20 mg mL−1) and incubated for 1 hour at RT.
Afterwards, 40 µL of each sample was transferred onto a cover-
slip. The coverslips were placed in a temperature controlled
plate to maintain the temperature at 37 °C. FCS measurements
were further performed as described in section 2.4.3.
2.8. In vitro transfection activity of polyplexes
In vitro studies were performed according to recommendations
as previously described.33 FaDu cells which stably express
firefly luciferase were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) with high glucose (4.5 g L−1 glucose) sup-
plemented with 10% FBS (referred to as full medium) at 37 °C
in a humidified atmosphere containing 5% CO2. Transfection
studies were done in 96-well plates, with FaDu-luc cells seeded
at a density of 7000 cells per well 24 hours before transfec-
tions. At the day of the experiment, cells were washed once
with PBS and incubated with 150 µL of various siRNA formu-
lations (anti-luciferase or negative control) in complete
medium for 6 hours at 37 °C. For the experiments with fresh
polyplexes, particles were prepared on the same day as
described in section 2.3 and subsequently diluted in full
medium (100 or 500 nM siRNA). Commercially available trans-
fection agents, l-PEI (25 kDa) and Lipofectamine 3000, were
included as positive controls and complexes were prepared
according to manufacturer’s protocol. Free siRNA, without a
transfection agent, was included as negative control. Cells
treated with only medium were used as negative control and
each condition was measured in octuple. For the released poly-
plexes, the supernatant from the hydrogels collected at various
timepoints (8, 24, 48 and 72 hours) was diluted with full
medium to yield a final siRNA concentration of 100 or 500 nM.
Each condition was measured in quadruple. All transfection
mixtures were replaced after 6 hours incubation by 200 µL
fresh medium and the plates were incubated for another
24 hours at 37 °C. After 16 hours, medium was replaced with
100 µL fresh medium containing 1× alamarBlue (50 nM) and
incubated for 4 hours at 37 °C to assess the cytotoxicity of the
tested formulations. From each well, 80 µL was transferred
into a new 96-well plate and the absorbance at 570 nm (taking
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630 nm as a reference) was measured using a BMG
SPECTROstar Nano wellplate reader (BMG Labtech, de Meern,
the Netherlands). Medium containing 1× alamarBlue was
included as blank. Data analysis was performed using MARS
Data analysis software version 2.22 (BMG Labtech) and cell via-
bility was calculated relative to untreated cells. To evaluate
siRNA-induced silencing, a Luciferase Assay was performed.
Medium was removed and the cells were lysed with 100 µL
lysis buffer (25 mM tris(hydroxymethyl)aminomethane (Tris),
2 mM dithiothreitol (DTT), 2 mM 1,2-diaminocyclohexane-
N,N,N′,N′-tetraacetic acid (DCTA), 1% Triton X-100, 10% glycerol)
on a shaking board at RT for 15 minutes. Thereafter, 50 µL of
lysate was transferred into a white luminescence plate and
50 µL of Luciferase Assay Reagent was injected using a
FLUOstar OPTIMA microplate reader (BMG Labtech,
Ortenberg, Germany) equipped with an injection pump. After
two seconds, luminescence was measured for ten seconds
according to supplier’s recommendation.
3. Results and discussion
3.1. Polymer synthesis and characterization
The NPD triblock copolymer consisting of a PEG midblock (P),
flanked by blocks of PNIPAM (N) and PDMAEMA (D) to intro-
duce thermosensitive and cationic properties into the polymer
structure, respectively, was synthesized and characterized
(Fig. 1A and Table 2). The polymer synthesis followed a two-
step synthesis route using a hetero-functional PEG macro-
initiator as reported before (Scheme S1†).26 In the first step,
NIPAM was polymerized by ATRP and the corresponding NPPN
polymer (N = PNIPAM, P = PEG) was obtained with a monomer
conversion of 92% based on 1H-NMR analysis and a yield of
90% (Table 2). Subsequently, classical free radical polymeriz-
ation was used to polymerize DMAEMA to yield the final NPD
triblock copolymer. DMAEMA conversion was 79% as deter-
mined with 1H-NMR and the polymer was obtained in a yield
of 71% (Table 2, Fig. S1†). A non-thermosensitive PD diblock
Fig. 1 (A) Chemical structure of NPD triblock polymer consisting of a 5 kDa PEG midblock (P), flanked by blocks of PNIPAM (N) and PDMAEMA (D).
(B) Chemical structure of PD diblock polymer consisting of a 5 kDa PEG block (P) and a PDMAEMA (D) block. (C) Chemical structure of NPN triblock
polymer consisting of a 6 kDa PEG block (P) flanked by blocks of PNIPAM (N).
Table 2 Characteristics of NPPN, NPD and PD block copolymers synthesized by radical polymerization using the hetero-functional PEG macro-
initiator. The polymer names are abbreviated according to the block composition (N = PN̲IPAM, P = P ̲EG, D = PD ̲MAEMA)
Name
Feed initiator : monomer
ratio (mol/mol)
Monomer
conversiona (%)
Mn N block
a
(kDa)
Mn P block
a
(kDa)
Mn D block
a
(kDa)
Total Mn
a
(kDa)
Total Mn
b
(kDa) PDIb
Cloud pointc
(°C)
NPPN 1 : 283 92 29 10 (2 × 5) n.a. 39 64 1.6 n.d.
NPD 1 : 790 79 15 5 49 69 51 1.9 34
PD 1 : 800 77 n.a. 5 47 52 32 2.1 n.d.
NPN 1 : 302 100 34 6 n.a. 40 45 1.2 35
aDetermined by 1H-NMR. bDetermined by GPC. cDetermined by light scattering at 550 nm. n.d. = not determined, n.a. = not applicable.
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copolymer lacking the PNIPAM block was also synthesized
(Fig. 1B) and a similar monomer conversion of DMAEMA
(77%) and polymer yield (68%) were obtained as for the NPD
polymer (Table 2, Fig. S2†). A NPN (N = PNIPAM, P = PEG) tri-
block copolymer (Fig. 1C) was synthesized according to a pre-
viously reported method27 and its characteristics are summar-
ized in Table 2. The monomer conversion based on 1H-NMR
analysis was 100% (Fig. S3†), and the obtained polymer had a
rather narrow polydispersity index (PDI 1.2), which is expected
for polymers synthesized by controlled radical polymerization.
The cloud points of the synthesized polymers (NPD and NPN)
were 34 and 35 °C, respectively (Table 2, Fig. S4†). The rheolo-
gical properties of the temperature dependent gelation behav-
ior of NPN, as well as representative images of the thermosen-
sitive hydrogel before and after gelation are shown in the ESI
(Fig. S5 and S6†). The injectability as previously shown by De
Graaf et al.,27 was confirmed by passing the solution through a
23 G needle.
3.2. Polyplex characterization
The thermosensitive NPD and the non-thermosensitive PD
polymers (Table 2) were used to prepare siRNA-containing
polyplexes at various N/P ratios. The N/P ratio is defined as the
molar ratio between the amine groups (N) on the cationic poly-
mers and the phosphate groups (P) on the siRNA. Increasing
the N/P molar ratio from 1 to 5 resulted in a significant
decrease in NPD polyplex size from 108 ± 1 to 23 ± 1 nm
(Fig. 2A). A further increase of the N/P ratio to 10 did not
result in a further decrease in the size of the polyplexes. The
same trend was observed for the PD polyplexes, for which a
decrease in polyplex size from 158 ± 1 to 23 ± 1 nm (N/P 1 and
5, respectively) was found upon increasing N/P ratio (Fig. 2A).
Interestingly, polyplexes prepared with N/P 1 had very narrow
size distributions (PDI < 0.1), while PDIs of polyplexes with
higher N/Ps increased but were still within an acceptable range
(<0.3) (Fig. 2B). The polyplexes prepared at an N/P ratio of
1 had a ζ-potential of −3 ± 1 mV and −1 ± 1 mV (NPD and PD
polyplexes, respectively) indicating incomplete shielding of the
siRNA molecules (Fig. 2C). As expected, with an increasing N/P
ratio of the formulation, due to the excess of cationic groups,
the polyplexes showed an increase in ζ-potential (up to + 9 ±
1 mV at an N/P ratio of 10 for PD polyplexes). Slightly higher
ζ-potentials were found for PD polyplexes as compared to NPD
polyplexes ( + 9 ± 1 mV and 5 ± 1 mV at N/P 10, respectively),
which can be explained by the additional shielding of the
hydrophilic PNIPAM block (below the CP) in the NPD poly-
plexes. Similar findings were also reported before for poly-
plexes containing pDNA.24 The ability of the cationic polymers
to complex with siRNA was evaluated by an agarose gel retar-
dation assay. Even at low N/P ratios, no free siRNA was
detected in the both types of polyplex dispersions, indicating
that all siRNA molecules complexed with the cationic polymers
Fig. 2 Characteristics of NPD and PD polyplexes prepared at different N/P ratios. (A & B) Particle size and polydispersity index (PDI) of the poly-
plexes containing non-coding siRNA (siRNA-nc) as determined by dynamic light scattering (DLS) in HBS buffer (20 mM HEPES, 150 mM NaCl, pH
7.4). All polyplexes were formed at 0 °C, and were subjected to a temperature change from 10 to 37 and back to 10 °C. An NPD polymer solution (no
siRNA added) was included as control for micelle formation at 37 °C. (C) ζ-Potential of polyplexes measured at 10 and 37 °C by laser Doppler electro-
phoresis (LDE) in HEPES buffer (20 mM HEPES, pH 7.4). All values are given as the mean ± SD (n = 3). (D) Agarose gel retardation assay of NPD and
PD polyplexes in HBS buffer (left). In parallel, heparin was added to destabilize the polyplexes and release siRNA from the cationic polymers (right).
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(Fig. 2D). To show the reversibility of the electrostatic inter-
actions, strongly negatively charged heparin was added to the
polyplexes, which resulted in release of siRNA (Fig. 2D).
3.3. Polyplex stability at 37 °C
Since the NPD polyplexes contain thermosensitive blocks, the
effect of temperature changes above (37 °C) and below (10 °C)
the CP was evaluated by DLS. For polyplexes prepared at N/P 1
and 3, increasing the temperature to 37 °C resulted in poly-
plexes with larger sizes (298 ± 3 at 37 °C and 362 ± 12 at 37 °C,
respectively) and broader size distributions (Fig. 2A and B). A
similar effect was observed for PD polyplexes with the same
N/P ratio, suggesting that the observed changes for NPD poly-
plexes with temperature are not caused by the thermosensitive
PNIPAM block. Additionally, the increase in size at 37 °C was
not completely reversible after cooling down the polyplexes
again to 10 °C (Fig. 2A). The size of NPD polyplexes at N/P1
increased from 108 ± 1 to 298 ± 3 nm upon heating from 10 to
37 °C, whereas upon cooling to 10 °C the size was 304 ± 6 nm.
Fig. 2A also shows that for the NPD polyplexes prepared at N/P
5 and 10, a significant increase in particle size (from ∼23 nm
to ∼170 nm) was observed when heated to 37 °C, which was
completely reversible after cooling down to 10 °C. The particle
size of PD polyplexes with N/P 5 and 10 remained unchanged
during the same temperature changes. At N/P 5 and 10, a large
excess of polymer is added to the siRNA, making it likely that
free polymer chains are present in the polyplex dispersion. In
addition, the free polymer chains can self-assemble into micel-
lar structures at 37 °C, because of the presence of the thermo-
sensitive PNIPAM blocks. Indeed, the control sample contain-
ing only NPD polymer, showed the presence of particles with a
similar size (∼165 nm) at 37 °C (Fig. 2A). In addition, the
ζ-potential of NPD polyplexes slightly increased at 37 °C which
can indicate the presence of positively charged micellar struc-
tures (Fig. 2C). The stability of the polyplexes was studied in
HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) over time.
DLS measurements showed that the size of PD polyplexes (N/P
5) remained constant (∼30 nm) after incubation for 16 hours
at 37 °C (Fig. 3B). Again, at 37 °C the size of the NPD poly-
plexes (N/P 5) significantly increased in time (from 25 to
120 nm), which was similar to the micelle size formed by the
NPD polymer alone (Fig. 3A and C). Cooling down the poly-
plexes to 10 °C after 16 hours incubation at 37 °C, resulted
again in only the small sized polyplexes (23 nm). Polyplexes
Fig. 3 Size of NPD and PD polyplexes (N/P 5) containing siRNA at 37 °C as determined by dynamic light scattering (DLS) in HBS buffer (20 mM
HEPES, 150 mM NaCl, pH 7.4) (A & B). NPD polymer solution (no siRNA added) was included as control for micelle formation at 37 °C (C). After
16 hours, the formulations were cooled down to 10 °C and measured again.
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prepared at N/P ratios of 1 and 3 showed significant increase
in size and PDI over time (Fig. S7†). From literature it is known
that among others particle size is a very important factor for
the uptake efficiency of complexes. For example, it has been
shown that the uptake efficiency of 20 and 40 nm nano-
particles was 5–10 times greater than that of 100 nm par-
ticles.34 Not only the efficiency of the uptake but also the type
of uptake pathway by which the particles are internalized, is
influenced by the size of the particles.35
Fluorescence correlation spectroscopy (FCS), a light
microscopy based technique used to study interactions on the
single molecule level, was exploited to further characterize the
thermosensitive polyplexes at 37 °C. FCS showed that free
siRNA in buffer and at 37 °C has a diffusion coefficient of 181
± 7 µm2 s−1 (Fig. 4A) which using the Stokes–Einstein equation
corresponds to a size of 2 nm, that is in line with earlier
reported sizes for siRNA molecules (Fig. 4B).36,37 FCS measure-
ments showed that the diffusion coefficient for both NPD and
PD polyplexes prepared at N/P ratio of 1 and 3 was ∼3 µm2 s−1,
which corresponds to a particle size of ∼100 nm (Fig. 4A and
B). On the other hand, the diffusion coefficients of polyplexes
prepared at higher N/P ratios 5 and 10 were around 10 times
larger (∼30 µm2 s−1) for both types of polymers. This diffusion
coefficient corresponds to a polyplex size of ∼10 nm, which is
in the same range as the small particle size found by DLS at
10 °C (Fig. 2A and Fig. 4B). These results confirm the presence
of micellar structures in the NPD polyplex dispersions, which
dominate the DLS measurement of NPD polyplexes (N/P 5 and
10) at 37 °C. Particles in a colloid dispersion scatter an inci-
dent laser beam, and the intensity of this scattered light is pro-
portional to the 6th power of the diameter of the particles.38 As
a consequence, the excessive scattering of bigger particles can
mask the low intensity scattering from smaller particles.39
Polyplexes with comparable small sizes (10–30 nm) have
been reported in literature before using various block
copolymers.40–45 For example, Hayashi et al. used poly(ethylene
glycol)-b-poly(L-lysine) (PEG–PLL) block copolymers to complex
siRNA and reported sizes of around 10 nm for polyplexes
based on this block copolymer.42 The authors attribute this
small size to a monomolecular assembly of the positively
charged polymer chain and the negatively charged siRNA
molecule. In other words, it is considered that each particle
consists of a single siRNA molecule complexed with one PEG–
PLL chain via electrostatic interactions. In the present study, it
is shown that the polyplex size is dependent on the N/P ratio,
where the small polyplexes are only observed at higher N/P
ratios (N/P ≥ 5). At higher N/P ratios, the siRNA molecules
become more diluted over the polymer chains making it poss-
ible that at some point the self-assembly behavior resembles
that of PEG–PLL, in which each polyplex contains a single
siRNA molecule. From the FCS data, an estimation of the
number of siRNA molecules per complex can be calculated by
normalizing the fluorescent particle concentration of the poly-
plexes to that of free siRNA,46 assuming that no quenching
occurs. If quenching would occur to a large extent, the peaks
in the FCS time traces are likely to disappear,47 which was not
observed (Fig. S8A, C, E and G†). It is determined that indeed
polyplexes prepared at N/P 5 and 10 contain between 1–3
siRNA molecules per complex compared to >100 siRNAs for
polyplexes at N/P 1 and 3 (Table 3).
Polyplexes prepared with both types of polymers at different
N/P ratios were incubated with or without fetal bovine serum
(FBS). A significant increase in polyplex size (from 149 ± 9 to
866 ± 204 nm) was observed for NPD polyplexes with N/P 1
when incubated without FBS for 6 hours at 37 °C, which is in
line with the DLS results (Fig. 2A and 4B). In contrast, the
Fig. 4 Characteristics of NPD and PD polyplexes prepared at different N/P ratios in HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) as determined
by fluorescence correlation spectroscopy (FCS). Diffusion coefficient (A) and size (B) of Alexa 647 siRNA in freshly prepared polyplexes was com-
pared with Alexa 647 siRNA in polyplexes incubated for 6 hours at 37 °C with or without FBS. Free Alexa 647 siRNA was included as control.
Measurements were performed at 37 °C. Mean ± SD (n = 3).
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observed sizes of the polyplexes at N/P 1 and 3 did not change
after incubation with FBS at 37 °C. However, the FCS time
traces showed a significant decrease in the count rate
(Fig. S8†), which might indicate aggregation and subsequent
sedimentation of the particles. Interestingly, FCS analysis
showed that the size of NPD and PD polyplexes prepared at
higher N/P ratios of 5 and 10 did not change significantly
when incubated at 37 °C for 6 hours without FBS (Fig. 4B).
However, in the presence of serum, the originally small sized
NPD polyplexes (size ∼10 nm; N/P 5 and 10) aggregate to
bigger particles of around 200 nm after 6 hours incubation
(Fig. 4B). It should be noted that such a polyplex size is still
generally considered acceptable to achieve efficient
transfection.11,48 The same trend was observed for the PD poly-
plexes (N/P 5 and 10) which increased slightly more in size to
around 400 nm after incubation with FBS for 6 hours at 37 °C
To evaluate whether siRNA loaded in NPD polyplexes is pro-
tected against degradation by RNases present in FBS, an
agarose retardation assay was performed (Fig. S9†). Compared
to the observed band for free siRNA in buffer (shown at N/P 0),
a time-dependent decrease in intensity was clearly seen when
siRNA was incubated with serum, indicating the presence of
nucleases in FBS. When the siRNA was complexed with poly-
mers, only the polyplexes with N/P 1 showed a significant
decrease in siRNA signal in the gel, while all other formu-
lations obviously protected the loaded siRNA against
degradation.
3.4. Hydrogel formation and siRNA release
Polyplexes prepared at N/P 5 were selected for further studies
because of their small size and excellent colloidal stability in
buffer and good stability in serum. These polyplexes were
loaded in a thermosensitive hydrogel based on the PNIPAM–
PEG–PNIPAM (NPN) triblock polymer by mixing NPD or PD
polyplexes (N/P 5) with a NPN solution at 4 °C and sub-
sequently increasing the temperature to 37 °C enabling gel for-
mation. Free siRNA was quantitatively released from the hydro-
gels in 50 hours (Fig. 5, circles). Moreover, a rapid release was
observed for this formulation, since 40% of the siRNA was
released after changing the release medium just once. When
siRNA was embedded in the hydrogel as polyplexes, a signifi-
cant slower and more controlled release was observed. For
both type of polyplexes (NPD and PD polyplexes), siRNA was
quantitatively released during 128 hours (Fig. 5, squares and
triangles). Furthermore, the amount of siRNA released was
rather similar per time point, which suggests that the release
of the polyplexes is dependent on the dissolution rate of the
hydrogel system. This is not completely surprising, since the
hydrogel is physically cross-linked and it has been reported
before that the equilibrium between the hydrogel and free
polymer chains in solution influences the dissolution rate of
such systems.27,49 The NPN triblock copolymers are known to
form micelles in aqueous solutions above their CP, and at
high concentrations the micelles are closely packed into a
hydrogel hold together by “bridging” chains. When this hydro-
gel is immersed into an aqueous medium, an equilibrium
between bridged micelles in the gel, free micelles and unimers
in solution is established.27,50 As a result, the frequency with
which the medium is refreshed determines the dissolution
rate of the hydrogel, and consequently the release of the
entrapped polyplexes. As a consequence, the release profiles
in vivo may be substantially different from the ones observed
in vitro studies because of a more dynamic environment
in vivo. The rationale for comparing the thermosensitive NPD
polyplexes with the non-thermosensitive PD polyplexes was
based on the hypothesis that, in the case of the NPD poly-
plexes, besides dissolution of the hydrogel also interactions
between the PNIPAM blocks in the polyplexes and those
present in the hydrogel may play a role in the kinetics of poly-
plex release. However, no significant differences in release
kinetics between the NPD and PD polyplexes were observed
(Fig. 5), indicating that the release of the polyplexes is gov-
erned by the dissolution rate of the hydrogel. Hydrogels can be
physically cross-linked by noncovalent interactions or chemi-
cally cross-linked by covalent bond formation, or via a combi-
nation of both. In this study, the thermosensitive physical
cross-linking causes the polyplex release to be dependent on
dissolution of the hydrogel matrix and not on degradation of
the chemical cross-links, which could offer an alternative strat-
egy to tune the release kinetics.
It is important to note that the siRNA quantification
measurements were performed after the addition of heparin to
Table 3 Polyplex size and estimation of number of siRNA molecules
per complex as determined by fluorescence correlation spectroscopy
(FCS). The polymer names are abbreviated according to the block com-
position (N = PN̲IPAM, P = P ̲EG, D = PD ̲MAEMA). Mean ± SD (n = 3)
Polymer
N/P
ratio
Polyplex size
(nm)
Number of siRNA
molecules per complex
NPD 1 149 ± 9 102 ± 2
3 88 ± 13 128 ± 9
5 10 ± 1 3 ± 1
10 12 ± 1 2 ± 1
PD 1 100 ± 16 132 ± 32
3 137 ± 22 109 ± 5
5 12 ± 1 2 ± 1
10 12 ± 1 1 ± 1
Fig. 5 Release of luciferase siRNA (siRNA-luc) from a thermosensitive
hydrogel in its free form, or formulated as NPD or PD polyplexes (N/P 5)
at 37 °C. The values are given as the mean ± SD (n = 3).
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dissociate the siRNA from the cationic polymers enabling
intercalating of the RiboGreen reagent. This means that the
detection does not discriminate between siRNA released in the
form of polyplexes or free siRNA. Moreover, analyzing the
release medium with dynamic light scattering does not give
insight whether polyplexes were released since this technique
detects both polyplexes and nanoparticulate fragments of the
hydrogel matrix. Therefore, FCS was used to evaluate whether
in the release samples free siRNA was present or siRNA in the
form of polyplexes. Since only the fluorescent signal of Alexa
Fig. 6 Characteristics of NPD and PD polyplexes (N/P 5) released from the thermosensitive hydrogel determined by fluorescence correlation spec-
troscopy (FCS) at 37 °C in HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4). (A & B) Diffusion coefficient and size, respectively, of free Alexa 647
siRNA and freshly prepared polyplexes compared with polyplexes released after 8 and 72 hours from the hydrogel. (C & D) Diffusion coefficient and
size, respectively, of Alexa 647 siRNA polyplexes released after 8 h with and without the addition of heparin. Free Alexa 647 siRNA was included as
control. Measurements were performed at 37 °C and the values are given as the mean ± SD (n = 3).
Fig. 7 (A) Agarose gel retardation assay of luciferase siRNA (siRNA-luc) released from the thermosensitive hydrogel when loaded in its free form, or
as NPD and PD polyplexes (N/P 5). (B) In parallel, heparin was added to destabilize the polyplexes and release siRNA from the cationic polymers.
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647 labeled siRNA was tracked, the presence of other particles
derived from degradation of the hydrogel did not influence the
measurement. The diffusion coefficient of free siRNA in buffer
was slightly higher than that of free siRNA in release medium
(181 ± 7 µm2 s−1 and 154 ± 17 µm2 s−1, respectively), indicating
only a minor effect of the NPN polymers on the viscosity of the
release medium (Fig. 6A). More importantly, FCS measure-
ments showed that the diffusion coefficients of NPD and PD
polyplexes released after 8 hours were comparable to those
before loading in the thermosensitive hydrogel (Fig. 6A),
demonstrating that intact polyplexes were released from the
thermosensitive hydrogel. The released polyplexes were similar
in size as the ones before encapsulation (Fig. 6B). Even after
72 hours, the diffusion coefficient, and correspondingly the
size, of the released NPD polyplexes were similar to freshly pre-
pared polyplexes. For the PD polyplexes, the diffusion coeffi-
cient after 72 hours was slightly decreased, which also trans-
lated into larger particles (Fig. 6B). This might be explained by
aggregation of the released polyplexes over time in the release
medium. To confirm that indeed polyplexes were released, the
strongly negatively charged heparin biopolymer was added to
the release medium (at 8 hours) and the resulting samples
were analyzed by FCS (Fig. 6C and D). For both type of poly-
plexes (NPD and PD polyplexes), the addition of this bio-
polymer resulted in an increase in diffusion coefficient from
∼38 µm2 s−1 to ∼165 µm2 s−1 (Fig. 6C). The larger diffusion
Fig. 8 In vitro transfection activity and cytotoxicity of freshly prepared and released NPD and PD polyplexes (N/P 5) on FaDu-luc cells. Cells were
transfected for 6 h at 37 °C with luciferase siRNA (siRNA-luc) in its free form or formulated as polyplexes with a final siRNA concentration of 100 or
500 nM in serum supplemented culture medium. As a positive control, Lipofectamine and PEI, 25 kDa (N/P 6) were included and prepared freshly on
the day of the experiment. As a negative control, non-coding siRNA (siRNA-nc) was included for all samples. Luciferase gene expression was deter-
mined by a luciferase reporter assay and plotted relative to untreated cells (A). Cell viability was determined by alamarBlue assay after incubation
with the different formulations (B). The values are given as the mean ± SD (n = 3).
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coefficient correlates perfectly with the value for free siRNA,
demonstrating destabilization of the polyplexes after addition
of heparin. To further support the finding that intact poly-
plexes were released, agarose gel assay was performed which
showed the absence of free siRNA (Fig. 7). Again, the addition
of heparin to the release medium resulted in dissociation of
the polyplexes, demonstrating also the reversibility of the com-
plexation. As expected, free siRNA was detected in the release
medium when incorporated into the hydrogel without the
presence of cationic polymers (Fig. 7).
3.5. In vitro transfection activity of polyplexes
The transfection efficiency and cytotoxicity of polyplexes based
on NPD and PD were evaluated in the presence of serum using
FaDu-luc cells (Fig. 8). For the freshly prepared NPD and PD
polyplexes, increasing the dose from 100 to 500 nM siRNA
resulted in a lower luciferase expression and thus increased
silencing (Fig. 8A). This increase in polyplex dose was associ-
ated with a slight drop in cell viability, which can be explained
by the higher concentration of the cationic polymer to which
the cells were exposed (Fig. 8B). It has been reported in many
papers that cationic polymers adversely affect the viability of
living cells.51,52 Furthermore, comparison of the silencing
effects between luciferase siRNA (Fig. 8A, closed bars) and the
non-coding siRNA (Fig. 8A, open bars) supports that the
observed reduced luminescence observed upon incubation of
the cells with the polyplex formulations was because of
specific silencing of the luciferase gene and not related to
their cytotoxicity. The commercially available transfection
reagent Lipofectamine was included as control, and resulted
in ∼30% knockdown of the luciferase gene. This observed
silencing effect of Lipofectamine is lower compared to the
∼80% luciferase silencing as reported before.43,53 This however
can be explained by differences in experimental conditions as
in this study transfections were performed in full medium sup-
plemented with FBS compared to serum-free conditions in
other studies. Polyplexes prepared with l-PEI (25 kDa) per-
formed in a similar way as the NPD and PD polyplexes with
the same siRNA dose. Incubation of the cells with siRNA in its
free form did not result in any luciferase gene silencing, which
confirms the requirement of a delivery system for these mole-
cules. The ability to induce siRNA-mediated gene silencing for
polyplexes after being released at different time points from
the hydrogel (Fig. 5 and Fig. S10†) was examined. Cells incu-
bated with the supernatant from the hydrogels containing
polyplexes showed a decrease in luciferase signal for all release
samples tested (8, 24, 48 and 72 hours) with a gene knockdown
ranging between 30–70% (Fig. 8A). These results further
support the finding that intact polyplexes were released from
the hydrogel, since siRNA released in its free form from the
hydrogel was not able to induce silencing of luciferase
(Fig. 8A). Additionally, limited cytotoxicity was observed for all
released formulations (Fig. 8B). Similar to the freshly prepared
polyplexes, increasing the polyplex dose from 100 to 500 nM
siRNA resulted in an increased luciferase silencing with mild
cytotoxicity (Fig. 8A and B). No significant differences in gene
silencing were observed between the NPD and PD polyplexes,
however, PD polyplexes (100 nM) were slightly cytotoxic
whereas NPD polyplexes were not (∼86% and ∼100% cell viabi-
lity respectively). Similar results were reported before for pDNA
polyplexes, where NPD polyplexes showed a better cytocompat-
ibility than PD polyplexes with similar efficiencies of delivering
its cargo into HeLa cells.24 Together, these data show that the
released siRNA polyplexes are able to enter cells and induce
gene silencing.
4. Conclusion
This study shows the feasibility of an injectable thermosensi-
tive hydrogel to promote local and sustained delivery of siRNA.
Both the NPD and PD polymers formed small nanosized poly-
plexes (10–20 nm) with siRNA when prepared at a N/P ratio of
5 or higher which were stable under physiological conditions.
Formulating siRNA into polyplexes using either the NPD or PD
polymer before loading into the thermosensitive hydrogel
resulted in a more controlled and sustained release compared
to free siRNA. The results presented here also demonstrate
that intact polyplexes were released suggesting that the hydro-
gel material does not compromise the polyplex stability.
Importantly, transfection experiments demonstrated that the
released polyplexes were still active by promoting the cellular
uptake and luciferase gene silencing in FaDu cells. This poly-
plex-hydrogel delivery approach could potentially be used to
deliver siRNA for various applications, such as the treatment
of tumors, where an injectable hydrogel is valuable for loca-
lized retention of the nucleic acid cargo.
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